Business Objects Selected by Allergan for Global Enterprise Deployment.

Business Editors/High-Tech Writers

SAN JOSE, Calif.--(BUSINESS WIRE)--Sept. 4, 2001

Business Objects (Nasdaq:BOBJ), the world's leading provider of business intelligence (BI) solutions, today announced that Allergan, Inc. (NYSE:AGN) a $1.6 billion global manufacturer and distributor of specialty pharmaceuticals, has chosen Business Objects to power its internal BI reporting system. This system will give employees quick access to information so they can more efficiently manage their business.

"An important reason we chose Business Objects was ease of use, and our end users preferred Business Objects over its competitors by a 9:1 ratio in the selection process," said Debbie Baughman, chief information officer at Allergan. "Also, we needed a vendor that could support a scalable, global deployment. The stable products, worldwide infrastructure, and proven success of enterprise deployments from Business Objects made it an easy choice as our enterprise standard."

Allergan, which develops and distributes products designed to treat specific diseases such as glaucoma, movement disorders, psoriasis, and acne, will use Business Objects to power its corporate reporting system, which will be rolled out to more than 2,500 employees globally over the next two and a half years. Allergan will use BusinessObjects(TM), the integrated query, reporting, and analysis solution for the enterprise, to provide employees a real-time view on key business metrics across the organization, such as sales performance and inventory analysis.

It will also use Broadcast Agent(TM), the integrated reporting and broadcasting server from Business Objects, to daily push out key performance information such as flash sales reports to executives. The result of this project will be the rollout of Business Objects as the enterprise dashboard to more than 20 countries around the world.

"We are in a market where new products are constantly being introduced and are leveraged by organizations for competitive advantage," added Baughman. "Business Objects BI solutions will let Allergan quickly access and analyze accurate information when and where we want it, giving us a faster reporting process, time and cost savings, and helping us always stay one step ahead of the competition."

Allergan relies on its information to be correct, timely, complete, and consistent and quick access to that data is crucial. Employees in Allergan's sales, marketing, manufacturing, and finance departments will use Business Objects to access, analyze, and share important sales, profit, inventory, and manufacturing cost information on all of its specialty pharmaceuticals.

"Leading companies realize that customer and market analysis provides insight into opportunities that otherwise may not be apparent and overlooked," said Alex Moissis, vice president of marketing for North America at Business Objects. "It is particularly rewarding to see how Business Objects is helping Allergan discover those opportunities and use them to help people around the world."

About Allergan, Inc.

Allergan, Inc., headquartered in Irvine, California, is a technology-driven global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets that deliver value to our customers, satisfy unmet medical needs, and improve patients' lives.

About Business Objects

Business Objects is the world's leading provider of business intelligence (BI) solutions. Business intelligence lets organizations access, analyze, and share information internally with employees and externally with customers, suppliers, and partners. It helps organizations improve operational efficiency, build profitable customer relationships, and develop differentiated product offerings.

The company's products include BusinessObjects 2000, the industry's leading integrated business intelligence toolset and platform; and BusinessObjects Analytics, an integrated suite of enterprise analytic applications.

Business Objects pioneered the modern BI industry in 1990 by inventing a patented "semantic layer" that insulates users from the complexity of databases. In 1995, the company was first to focus on enterprise-scale BI deployments and today supports customers with more than 20,000 users. The company moved aggressively to the internet in 1997 by pioneering the market for BI extranets, a market that it continues to lead today. In 2000, the company delivered the industry's first interactive mobile BI solution. Today, Business Objects continues to innovate, creating and delivering a unique vision for enterprise analytic applications.

Business Objects has more than 13,000 customers in over 80 countries. The company's stock is publicly traded under the ticker symbols NASDAQ:BOBJ and Euronext Paris (Sicovam code 12074). It is included in the SBF 120 and IT CAC 50 French stock market indexes. Business Objects can be reached at 408-953-6000 and www.businessobjects.com.

BusinessObjects and Broadcast Agent are trademarks of Business Objects SA.

A full-text copy of this announcement may be downloaded from the web; access www.businesswire.com and search on "Business Objects." Business Objects product inquiries should contact 800-527-0580.